# Cigna Group: filings

CI · NYSE · CIK 1739940 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ci.md) · [Financials](/companies/ci/financials.md) · [Filings](/companies/ci/filings.md) · [Insiders](/companies/ci/insiders.md)

## Reports and events: 175 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 602, 8-K 131, 144 65, 3 47, 10-Q 23, DEFA14A 20, SC 13G/A 17, CORRESP 12, SC 13G 9, 10-K 8, 11-K 8, DEF 14A 8, UPLOAD 8, 424B3 7, 424B5 6, PX14A6G 6, 8-K/A 5, FWP 5, S-4/A 5, 4/A 4, ARS 4, SCHEDULE 13G/A 4, EFFECT 3, S-3ASR 3, S-4 3, S-8 3, 8-K12B 1, PRE 14A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-09 | 20:15 ET | [8-K](/filings/0001140361-26-039271.md) | 5.02 Departure or appointment of officers or directors | 0001140361-26-039271 |
| 2026-09-30 | 11:12 ET | [8-K](/filings/0001140361-26-038056.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-038056 |
| 2026-07-30 | 16:37 ET | [10-Q](/filings/0001739940-26-000065.md) | Quarterly report, period 2026-06-30 | 0001739940-26-000065 |
| 2026-07-30 | 10:16 ET | [8-K](/filings/0001140361-26-030135.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-030135 |
| 2026-05-13 | 10:01 ET | [8-K](/filings/0001140361-26-020906.md) | 7.01 Regulation FD disclosure | 0001140361-26-020906 |
| 2026-04-30 | 15:47 ET | [10-Q](/filings/0001739940-26-000043.md) | Quarterly report, period 2026-03-31 | 0001739940-26-000043 |
| 2026-04-30 | 10:15 ET | [8-K](/filings/0001140361-26-017971.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-017971 |
| 2026-04-27 | 20:26 ET | [8-K](/filings/0001140361-26-017123.md) | 5.07 Shareholder vote results | 0001140361-26-017123 |
| 2026-03-13 | 20:36 ET | [DEF 14A](/filings/0001739940-26-000023.md) | Proxy statement, period 2026-04-22 | 0001739940-26-000023 |
| 2026-03-03 | 12:42 ET | [8-K](/filings/0001140361-26-007450.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-007450 |
| 2026-02-27 | 11:15 ET | [8-K](/filings/0001140361-26-007049.md) | 7.01 Regulation FD disclosure | 0001140361-26-007049 |
| 2026-02-26 | 17:08 ET | [10-K](/filings/0001739940-26-000006.md) | Annual report, period 2025-12-31 | 0001739940-26-000006 |
| 2026-02-05 | 11:15 ET | [8-K](/filings/0001140361-26-003768.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-003768 |
| 2025-11-18 | 21:15 ET | [8-K](/filings/0001140361-25-042597.md) | 8.01 Other events | 0001140361-25-042597 |
| 2025-10-30 | 16:20 ET | [10-Q](/filings/0001739940-25-000037.md) | Quarterly report, period 2025-09-30 | 0001739940-25-000037 |
| 2025-10-30 | 10:15 ET | [8-K](/filings/0001140361-25-039777.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-039777 |
| 2025-10-20 | 20:16 ET | [8-K](/filings/0001140361-25-038670.md) | 5.02 Departure or appointment of officers or directors | 0001140361-25-038670 |
| 2025-09-04 | 20:08 ET | [8-K](/filings/0001140361-25-033986.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-033986 |
| 2025-09-02 | 10:30 ET | [8-K](/filings/0001140361-25-033536.md) | 7.01 Regulation FD disclosure | 0001140361-25-033536 |
| 2025-07-31 | 17:36 ET | [10-Q](/filings/0001739940-25-000028.md) | Quarterly report, period 2025-06-30 | 0001739940-25-000028 |
| 2025-07-31 | 10:15 ET | [8-K](/filings/0001140361-25-028099.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-028099 |
| 2025-07-28 | 20:16 ET | [8-K/A](/filings/0001140361-25-027585.md) | 5.02 Departure or appointment of officers or directors | 0001140361-25-027585 |
| 2025-06-02 | 21:03 ET | [8-K](/filings/0001140361-25-021143.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-021143 |
| 2025-05-20 | 10:01 ET | [8-K](/filings/0001140361-25-019807.md) | 7.01 Regulation FD disclosure | 0001140361-25-019807 |
| 2025-05-02 | 15:07 ET | [10-Q](/filings/0001739940-25-000021.md) | Quarterly report, period 2025-03-31 | 0001739940-25-000021 |
| 2025-05-02 | 10:16 ET | [8-K](/filings/0001140361-25-017006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-017006 |
| 2025-04-28 | 20:15 ET | [8-K](/filings/0001140361-25-016027.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001140361-25-016027 |
| 2025-04-18 | 20:20 ET | [8-K](/filings/0001140361-25-014574.md) | 5.02 Departure or appointment of officers or directors | 0001140361-25-014574 |
| 2025-03-19 | 12:25 ET | [8-K](/filings/0001140361-25-009365.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-009365 |
| 2025-03-14 | 20:35 ET | [DEF 14A](/filings/0001739940-25-000015.md) | Proxy statement, period 2025-04-23 | 0001739940-25-000015 |
| 2025-03-13 | 11:42 ET | [8-K](/filings/0001140361-25-008555.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001140361-25-008555 |
| 2025-03-03 | 21:15 ET | [8-K](/filings/0001140361-25-006753.md) | 7.01 Regulation FD disclosure | 0001140361-25-006753 |
| 2025-02-27 | 18:38 ET | [10-K](/filings/0001739940-25-000009.md) | Annual report, period 2024-12-31 | 0001739940-25-000009 |
| 2025-01-30 | 11:15 ET | [8-K](/filings/0001140361-25-002386.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-002386 |
| 2024-10-31 | 17:36 ET | [10-Q](/filings/0001739940-24-000033.md) | Quarterly report, period 2024-09-30 | 0001739940-24-000033 |
| 2024-10-31 | 10:15 ET | [8-K](/filings/0001140361-24-044674.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-044674 |
| 2024-09-03 | 10:15 ET | [8-K](/filings/0000950159-24-000274.md) | 7.01 Regulation FD disclosure | 0000950159-24-000274 |
| 2024-08-01 | 14:34 ET | [10-Q](/filings/0001739940-24-000028.md) | Quarterly report, period 2024-06-30 | 0001739940-24-000028 |
| 2024-08-01 | 10:15 ET | [8-K](/filings/0000950159-24-000233.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950159-24-000233 |
| 2024-06-20 | 20:15 ET | [8-K](/filings/0000950159-24-000218.md) | 5.02 Departure or appointment of officers or directors | 0000950159-24-000218 |
| 2024-06-06 | 10:15 ET | [8-K](/filings/0000950159-24-000212.md) | 7.01 Regulation FD disclosure | 0000950159-24-000212 |
| 2024-05-02 | 15:10 ET | [10-Q](/filings/0001739940-24-000015.md) | Quarterly report, period 2024-03-31 | 0001739940-24-000015 |
| 2024-05-02 | 10:15 ET | [8-K](/filings/0000950159-24-000134.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950159-24-000134 |
| 2024-04-26 | 20:30 ET | [8-K](/filings/0000950159-24-000132.md) | 5.07 Shareholder vote results | 0000950159-24-000132 |
| 2024-04-26 | 10:15 ET | [8-K](/filings/0000950159-24-000130.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events | 0000950159-24-000130 |
| 2024-03-15 | 20:16 ET | [DEF 14A](/filings/0001739940-24-000010.md) | Proxy statement, period 2024-04-24 | 0001739940-24-000010 |
| 2024-03-07 | 11:55 ET | [8-K](/filings/0000950159-24-000103.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950159-24-000103 |
| 2024-02-29 | 19:48 ET | [10-K](/filings/0001739940-24-000005.md) | Annual report, period 2023-12-31 | 0001739940-24-000005 |
| 2024-02-15 | 11:16 ET | [8-K](/filings/0000950159-24-000100.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950159-24-000100 |
| 2024-02-13 | 21:06 ET | [8-K](/filings/0001140361-24-007429.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-007429 |

Page 1 of 4. [Older](/companies/ci/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.